Over the weekend, the long-awaited update of Lung-RADS was published with changes that aim to reduce lung cancer screening false positives by downgrading many category 3 findings to category 2. Lung-RADS (lung imaging reporting and data system) is a quality assurance tool to aid with findings in low-dose CT screenings for lung cancer. First introduced in 2014 by the American College of Radiology, Lung-RADS aims to standardize recommendations, reduce confusion in screening interpretations, and facilitate outcome monitoring. Here are the [...]
Lung cancer screening. You may have seen it on the news or an advertisement for it, but what is it and does it make sense for you? Screening refers to a test for individuals considered to be at high risk for a disease before they have symptoms. Lung cancer often has no symptoms until it has spread due to a lack of pain receptors in the lungs. The only proven method to detect lung cancer at an early and treatable [...]
By Amy Copeland, MPH, Director of Medical Outreach at Lung Cancer Alliance Public Health Week (April 2-9) got us thinking….What exactly is public health and how does it relate to lung cancer? We sat down with Amy Copeland, Lung Cancer Alliance’s (LCA) Director of Medical Outreach, who received her Masters of Public Health from George Washington University and has spent just shy of 20 years in the field, to ask these important questions, as well as learn a little about [...]
Sheila Ross, a pioneering lung cancer advocate who founded Lung Cancer Alliance’s presence on Capitol Hill, was recently profiled by the Annapolis, Maryland-based Capital Gazette. The article traces both Sheila’s cancer journey and the advocacy measures that brought heightened awareness and landmark legislation on low dose CT screening for early detection. Read more about how Sheila faced her diagnosis with action in the Capital Gazette.